Bacteria-Based Delivery System Offers New Path to Norovirus Treatment

Researchers have engineered lactobacilli—common gut bacteria—to deliver nanobodies, tiny antibody fragments that combat norovirus infection. The approach could bypass traditional manufacturing constraints and enable oral delivery directly in the digestive tract, potentially transforming how infectious disease treatments reach patients.

Originaltitel: Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus Infection